Neutrogena Oil Free Acne Wash Cleanser

Description

This oil-free acne wash cream cleanser utilizes MICRO CLEAR® technology, providing an effective yet gentle treatment for acne. Formulated with salicylic acid, it targets acne while being suitable for various skin types. The product is recommended by dermatologists and is available in a 6.7 FL. OZ. (200 mL) size. Neutrogena® is the brand associated with this formulation.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should instruct patients to wet their face prior to application. A sufficient amount of the product should be squeezed into the hands and then gently massaged onto the face. Following application, it is essential to rinse the face thoroughly with water.

In cases where patients experience excess drying or peeling, it is recommended to reduce the frequency of application to every other day to mitigate these effects.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to adhere to the following precautions:

• The product should be kept out of reach of children. In the event of accidental ingestion, seek medical assistance or contact a Poison Control Center immediately.

• Avoid contact with eyes. If contact occurs, it is recommended to flush the eyes thoroughly with water.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In cases where irritation is observed, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

It is imperative to avoid contact with the eyes. Should contact occur, patients should be instructed to flush the eyes thoroughly with water to prevent potential complications.

Additionally, this product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware that it is for external use only. The most common adverse reactions reported include skin irritation and dryness, particularly when used concurrently with other topical acne medications. To minimize the risk of irritation, it is advised that patients use only one topical acne medication at a time.

In the event of contact with the eyes, patients should flush the area thoroughly with water. Additionally, if the product is swallowed, it is crucial to seek medical assistance or contact a Poison Control Center immediately. These precautions are important to ensure the safety and well-being of patients using this topical treatment.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Neutrogena Oil Free Acne Wash Cleanser (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of Neutrogena Oil-Free Acne Wash Cleanser in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise clinical judgment when considering the use of this product in the geriatric population, as individual patient factors may influence safety and efficacy. Monitoring for any adverse reactions or sensitivities is advisable when this product is used in elderly patients.

Pregnancy

The product has not been specifically studied in pregnant patients, and there are no explicit warnings or precautions regarding its use during pregnancy. As such, the potential risks to fetal outcomes remain unclear. Healthcare professionals should consider the lack of data when prescribing this product to women of childbearing potential and weigh the benefits against any potential risks. It is advisable to discuss the use of this product with pregnant patients or those planning to become pregnant to ensure informed decision-making.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available concerning the potential for excretion in breast milk or any effects on breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation are recommended to ensure patient safety and effective resolution of any complications arising from the overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the provided data.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. Instruct patients that if the medication is swallowed, they should seek medical help or contact a Poison Control Center immediately.

It is important to inform patients that skin irritation and dryness may be more likely to occur if they are using another topical acne medication concurrently. Therefore, they should be counseled to use only one topical acne medication at a time to minimize the risk of irritation.

Patients should also be cautioned to avoid contact with their eyes. In the event of accidental contact, they should flush their eyes thoroughly with water and seek medical attention if irritation persists.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its efficacy and integrity. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

The product is administered topically and is intended for external use only. Clinicians should advise patients that the use of multiple topical acne medications concurrently may increase the risk of skin irritation and dryness. If irritation occurs, patients are recommended to limit use to one topical acne medication at a time.

Patients should be cautioned to avoid contact with the eyes; in the event of contact, they should flush the area thoroughly with water. Additionally, the product should be kept out of reach of children, and if swallowed, immediate medical assistance or contact with a Poison Control Center is necessary.

Drug Information (PDF)

This file contains official product information for Neutrogena Oil Free Acne Wash Cleanser, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)